Medicines Co. Stock
-
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
Cons
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Repligen Corp. | -0.340% | 2.585% | 1.456% | -10.830% | 1.420% | -15.951% | -20.705% |
| Opko Health Inc. | 6.810% | 5.707% | 2.991% | -17.568% | 2.954% | -13.342% | -68.560% |
| Amicus Therapeutics Inc. | 1.670% | 0.000% | 32.609% | 34.807% | 1.667% | 2.797% | -29.070% |
Comments
News
Why Revolution Medicines Stock Surged by 11% Today
More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That was the dynamic behind the nearly 11% price gain of Revolution Medicines
Why Praxis Precision Medicines Stock Popped Today
Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor
Meet the Biotech Stock That Just Jumped 251% Higher
Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can


